-
My Account
In App
My Account
BSE Live
Oct 28, 16:01Prev. Close
1458.40
Open Price
1460.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 28, 15:59Prev. Close
1457.70
Open Price
1457.70
Bid Price (Qty.)
1432.00 (24)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Concord Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | |
| 12 mths | 12 mths | ||
| INCOME | |||
| Revenue From Operations [Gross] | 1,179.82 | 998.06 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 1,179.82 | 998.06 | |
| Total Operating Revenues | 1,200.09 | 1,016.94 | |
| Other Income | 44.45 | 33.78 | |
| Total Revenue | 1,244.53 | 1,050.72 | |
| EXPENSES | |||
| Cost Of Materials Consumed | 264.31 | 184.54 | |
| Purchase Of Stock-In Trade | 55.99 | 56.74 | |
| Operating And Direct Expenses | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -14.79 | -12.08 | |
| Employee Benefit Expenses | 138.93 | 123.05 | |
| Finance Costs | 0.53 | 2.55 | |
| Depreciation And Amortisation Expenses | 54.37 | 53.59 | |
| Other Expenses | 249.31 | 233.14 | |
| Total Expenses | 748.66 | 641.53 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 495.88 | 409.19 | |
| Exceptional Items | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 495.88 | 409.19 | |
| Tax Expenses-Continued Operations | |||
| Current Tax | 118.96 | 99.83 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | |
| Deferred Tax | 3.95 | 4.63 | |
| Other Direct Taxes | 0.00 | 0.00 | |
| Total Tax Expenses | 122.91 | 104.46 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 372.96 | 304.73 | |
| Profit/Loss From Continuing Operations | 372.96 | 304.73 | |
| Profit/Loss For The Period | 372.96 | 304.73 | |
| Minority Interest | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 371.64 | 308.10 | |
| OTHER ADDITIONAL INFORMATION | |||
| EARNINGS PER SHARE | |||
| Basic EPS (Rs.) | 36.00 | 29.00 | |
| Diluted EPS (Rs.) | 36.00 | 29.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||
| Equity Share Dividend | 91.54 | 71.45 | |
| Tax On Dividend | 0.00 | 0.00 |
22.08.2025
Concord Biotech Standalone June 2025 Net Sales at Rs 203.99 crore, down 5.47% Y-o-Y
12.06.2025
Concord Biotech Standalone March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y
05.06.2025
Concord Biotech Consolidated March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y
04.03.2025
Concord Biotech Consolidated December 2024 Net Sales at Rs 244.22 crore, up 1.42% Y-o-Y
